SARS-CoV-2 (COVID-19) eCase Study Series
About The Series
This three part GenomeWeb eCase study series, sponsored by LGC SeraCare Life Sciences, addresses SARS-CoV-2 quality solutions, verification panels and reference materials.
PART 1 | Presenter: Jeff SoRelle, M.D., Clinical Pathology Resident, University of Texas Southwestern Medical Center
Experience with SARS-CoV-2 (COVID-19) Assay Validation
In this 20 minute eCase Study you will hear first-hand how Dr. Jeff SoRelle and team, of the University of Texas Southwestern Medical Center, developed and validated a COVID-19 RT PCR assay. Jeff shares his decision to bring this development in house, how he chose reference materials, and how he managed to scale up and provide rapid turnaround.
PART 2 | Presenter: Joel Lefferts, PhD, HCLD, DABCC, Assistant Director of Clinical Genomics and Advanced Technology Lab and Assistant Professor of Pathology and Laboratory Medicine Dartmouth-Hitchcock Medical Center and Geisel School of Medicine at Dartmouth
Rapid Implementation of SARS-CoV-2 Testing
Hear how Dr. Joel Lefferts and his team at the Dartmouth-Hitchcock Medical Center were able to rapidly increase, through automation, their SARS-VoV-2 assay on the Abbott M2000. Joel will provide practical experiences and challenges faced when developing, validating and going live with a SARS CoV-2 assay to facilitate patient testing.
PART 3 | Presenter: Russell Garlick, PhD, Chief Scientific Officer, LGC SeraCare Life Sciences
Expert Advice Establishing a SARS-CoV-2 Assay for COVID-19
Learn how Accuplex™ SARS-CoV-2 Reference Materials are meeting the immediate need, and the critical role they play in validating the performance of Coronavirus Assay. The focus is on the technology, the importance of early detection and helping every lab accelerate go live launch.